Use of Upadacitinib in Real-World Clinical Practice: Patient Characteristics and Glucocorticoid-Sparing Effect
Por:
Ruiz-Esquide, V, Mateo, L, Garc a, CP, Sang-Park, H, Holgado, S, Aparicio, M, Frade, B, Sarmiento-Monroy, JC, Nack, A, Garcia, FJR, Gomez-Puerta, J and Sanmart , R
Publicada:
1 oct 2025
Resumen:
Filiaciones:
Ruiz-Esquide, V:
Hosp Clin Barcelona, Barcelona, Catalonia, Spain
:
Hosp Trias & Pujol, Barcelona, Spain
Garc a, CP:
Hosp del Mar, Barcelona, Spain
Sang-Park, H:
Hosp Santa Creu & Sant Pau, Barcelona, Catalonia, Spain
Holgado, S:
Hosp Badalona Germans Trias & Pujol, Barcelona, Catalonia, Spain
:
Hosp Badalona Germans Trias & Pujol, Barcelona, Catalonia, Spain
Frade, B:
Hosp Clin Barcelona, Barcelona, Catalonia, Spain
Sarmiento-Monroy, JC:
Hosp Clin Barcelona, Barcelona, Catalonia, Spain
Nack, A:
Hosp Badalona Germans Trias & Pujol, Barcelona, Catalonia, Spain
Garcia, FJR:
Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain
IDIBAPS Barcelona, Barcelona, Spain
Gomez-Puerta, J:
Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain
Sanmart , R:
Hosp Clin Barcelona, Barcelona, Catalonia, Spain
|